Top 6 Malpractice Consult articles of 2019
Here are the six most-read “Malpractice Consult” columns of 2019 from Brianne Goodwin, JD, RN, and Acacia Brush Perko, Esq.
Related Articles
PSMA-PET shows diagnostic accuracy in initial staging of prostate cancer
The investigators found a positive correlation between PSA levels and SUVmax.
Investigators identify potential dual targets in prostate cancer
“Our findings highlight the coordinated interplay between GCN2 and p53 regulation during nutrient stress and provide insight into how they could be targeted in developing…
Investigators identify potential dual targets in prostate cancer
“Our findings highlight the coordinated interplay between GCN2 and p53 regulation during nutrient stress and provide insight into how they could be targeted in developing…
Juan J. Andino, MD, on key concerns surrounding the future of telehealth
“The other aspects of the waivers and the things that remain in flux and are not fully fleshed out are going to be things like…
Wayne Kuang, MD, on rethinking bladder health in men with BPH
“There are only 2 major organs you can’t transplant: the brain and the bladder. So let’s take care of the bladder,” says Wayne Kuang, MD.
First patient dosed in phase 1 trial of ADI-270 in ccRCC
Initial data from the trial are expected to be released in the first half of 2025.
FDA greenlights phase 1/2 trial of gene editing therapy for primary hyperoxaluria 1
The redePHine trial is expected to launch in the first half of 2025.
Expert compares Aquablation with TURP for treatment of BPH
“The main benefit, I guess, for Aquablation over TURP, is the fact that the sexual side effects are much better when compared to TURP,” says…
Eric Jonasch, MD, on phase 1/2 trial of 177Lu-girentuximab combination in ccRCC
“We really want to understand whether by using this beta emitter, together with the combination of cabazantinib and the nivolumab, we’re getting better outcomes than…
NCCN reaffirms Prolaris’ prognostic value in prostate cancer
The inclusion of the test is supported by more than 25 studies demonstrating its clinical utility, including 2 studies published earlier this year.